Laurent Gauthier

This inventor holds 42 USPTO granted patents and 35 published patent applications, plus 10 CIPO patents and 24 EPO patents, primarily in NK Cell Engagers. Top assignees: Innate Pharma, Paul Scherrer Institut, University of Genoa. Active years: 2012-2026.

USPTO Granted Patents = 42 (Patent Applications = 35)

% Patents Active = 83.3

CIPO Patents = 10 (Patent Applications = 21)

EPO Patents = 24 (Patent Applications = 44)

Average Co-Inventor Count = 4.3

ph-index = 9

Forward Citations = 227(Granted Patents)

Location History:

Marseille, FR (2012 - 2018)
Marseilles, FR (2012 - 2024)

Company Filing History:

Paul Scherrer Institut

Novo Nordisk-a/s Novo Alle

where one patent can have more than one assignee

Years Active: 2012-2026

Loading Chart...

Areas of Expertise:

NK Cell Engagers

CD73 Blocking Antibodies

NKp46 Binding Agents

Multispecific Antigen Binding Proteins

Humanized Antibodies

Siglec-9 Antibodies

KIR3DL2 Binding Agents

Enzymatic Conjugation

TLR3 Binding Agents

NK Cell Activity Regulation

Anti-KIR3D Antibodies

Nucleic Acids

42 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12528876 - CD73 BLOCKING ANTIBODIES (2026-01-20),

2. 12365731 - NKp46 binding agents (2025-07-22),

3. 12252543 - Multispecific NK engager protein (2025-03-18),

4. 12227569 - Humanized antibodies with increased stability (2025-02-18),

5. 12202907 - Nucleic acids encoding and methods of producing proteins comprising antibody chains (2025-01-21),

6. 12195555 - Natural killer (NK) cell engagers binding to NKp46 and BCMA variants with Fc-engineering (2025-01-14),

7. 11958907 - CD73 blockade (2024-04-16),

8. 11891444 - Variable regions for NKp46 binding proteins (2024-02-06),

9. 11858990 - KIR3DL2 binding agents (2024-01-02),

10. 11845795 - NKp46 binding proteins (2023-12-19),

11. 11692039 - Multifunctional natural killer (NK) cell engagers binding to NKp46 and CD123 (2023-07-04),

12. 11623954 - Siglec-9-neutralizing antibodies (2023-04-11),

13. 11377503 - Antibodies that bind human CD39 and inhibit ATPase activity of a soluble extracellular domain human CD39 polypeptide (2022-07-05),

14. 11377492 - NKp46 binding agents (2022-07-05),

15. 11267897 - Multispecific NK engager protein (2022-03-08),

Title: Inventor Laurent Gauthier: Pioneering Innovations from Marseilles, FR

Introduction: Laurent Gauthier is a visionary inventor hailing from the vibrant city of Marseilles, France. With a passion for pushing the boundaries of technology, he has made significant contributions to the field of inventions.

Latest Patents: Laurent Gauthier holds several groundbreaking patents in various industries, showcasing his versatility and creativity in developing novel solutions to complex problems.

Career Highlights: Throughout his illustrious career, Laurent Gauthier has been recognized for his innovative spirit and dedication to creating cutting-edge inventions. His work has not only transformed industries but has also inspired the next generation of inventors.

Collaborations: Laurent Gauthier has collaborated with leading research institutions, universities, and companies worldwide to bring his ideas to life. His ability to work in diverse teams has led to the successful implementation of numerous revolutionary projects.

Conclusion: Laurent Gauthier's impact on the world of inventions is truly remarkable, and his legacy will continue to inspire future generations of inventors to think outside the box and pursue their innovative ideas relentlessly.